Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Larkin, J.M.G.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(4)
+
-
Creation Date
2014
(3)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Scholarly Publications
(2)
+
-
Author
Larkin, J.M.G.
(6)
+
-
Blank, C.U.
(4)
+
-
Kapiteijn, E.
(3)
+
-
Lorigan, P.
(3)
+
-
Carlino, M.S.
(2)
+
-
Carvajal, R.D.
(2)
+
-
Eertwegh, A.J.M. van den
(2)
+
-
Furness, A.J.S.
(2)
+
-
Gore, M.E.
(2)
+
-
Haanen, J.B.A.G.
(2)
+
-
Heemskerk, B.
(2)
+
-
Hodi, F.S.
(2)
+
-
Jansen, R.L.
(2)
+
-
Johnson, D.B.
(2)
+
-
Kelderman, S.
(2)
+
-
Krzystanek, M.
(2)
+
-
Long, G.V.
(2)
+
-
Luke, J.J.
(2)
+
-
Menzies, A.M.
(2)
+
-
Piperno-Neumann, S.
(2)
+
-
Renn, A.
(2)
+
-
Roozen, I.
(2)
+
-
Schwartz, G.K.
(2)
+
-
Seifert, H.
(2)
+
-
Szallasi, Z.
(2)
+
-
Tinteren, H. van
(2)
+
-
Yerramilli-Rao, P.
(2)
+
-
Zoubir, M.
(2)
+
-
Show more
Language
en
(6)
+
-
Search results
(1 - 6 of 6)
show grid
show list
save search
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Landscape of genetic alterations in patients with metastatic uveal melanoma
Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma
Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma